232 related articles for article (PubMed ID: 21852813)
1. A losing battle: weight regain does not restore weight loss-induced bone loss in postmenopausal women.
Villalon KL; Gozansky WS; Van Pelt RE; Wolfe P; Jankowski CM; Schwartz RS; Kohrt WM
Obesity (Silver Spring); 2011 Dec; 19(12):2345-50. PubMed ID: 21852813
[TBL] [Abstract][Full Text] [Related]
2. Weight-loss-associated changes in bone mineral density and bone turnover after partial weight regain with or without aerobic exercise in obese women.
Hinton PS; Rector RS; Linden MA; Warner SO; Dellsperger KC; Chockalingam A; Whaley-Connell AT; Liu Y; Thomas TR
Eur J Clin Nutr; 2012 May; 66(5):606-12. PubMed ID: 22190134
[TBL] [Abstract][Full Text] [Related]
3. Serum 25-hydroxyvitamin D and bone turnover markers in Palestinian postmenopausal osteoporosis and normal women.
Kharroubi A; Saba E; Smoom R; Bader K; Darwish H
Arch Osteoporos; 2017 Dec; 12(1):13. PubMed ID: 28124221
[TBL] [Abstract][Full Text] [Related]
4. Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1-34)] in postmenopausal osteoporosis.
Cosman F; Eriksen EF; Recknor C; Miller PD; Guañabens N; Kasperk C; Papanastasiou P; Readie A; Rao H; Gasser JA; Bucci-Rechtweg C; Boonen S
J Bone Miner Res; 2011 Mar; 26(3):503-11. PubMed ID: 20814967
[TBL] [Abstract][Full Text] [Related]
5. Does Diet-Induced Weight Loss Lead to Bone Loss in Overweight or Obese Adults? A Systematic Review and Meta-Analysis of Clinical Trials.
Zibellini J; Seimon RV; Lee CM; Gibson AA; Hsu MS; Shapses SA; Nguyen TV; Sainsbury A
J Bone Miner Res; 2015 Dec; 30(12):2168-78. PubMed ID: 26012544
[TBL] [Abstract][Full Text] [Related]
6. The levels of bone turnover markers 25(OH)D and PTH and their relationship with bone mineral density in postmenopausal women in a suburban district in China.
Gao C; Qiao J; Li SS; Yu WJ; He JW; Fu WZ; Zhang ZL
Osteoporos Int; 2017 Jan; 28(1):211-218. PubMed ID: 27468899
[TBL] [Abstract][Full Text] [Related]
7. The effect of weight and weight change on the long-term precision of spine and hip DXA measurements.
Rajamanohara R; Robinson J; Rymer J; Patel R; Fogelman I; Blake GM
Osteoporos Int; 2011 May; 22(5):1503-12. PubMed ID: 20700581
[TBL] [Abstract][Full Text] [Related]
8. The relationship between the metabolic syndrome and its components and bone status in postmenopausal women.
Fodor D; Vesa S; Albu A; Simon S; Craciun A; Muntean L
Acta Physiol Hung; 2014 Jun; 101(2):216-27. PubMed ID: 24901081
[TBL] [Abstract][Full Text] [Related]
9. Maintenance of muscle strength may counteract weight-loss-related postmenopausal bone loss--a population-based approach.
Sirola J; Rikkonen T; Tuppurainen M; Honkanen R; Jurvelin JS; Kröger H
Osteoporos Int; 2006; 17(5):775-82. PubMed ID: 16491321
[TBL] [Abstract][Full Text] [Related]
10. Influence of weight and weight change on bone loss in perimenopausal and early postmenopausal Scottish women.
Macdonald HM; New SA; Campbell MK; Reid DM
Osteoporos Int; 2005 Feb; 16(2):163-71. PubMed ID: 15185065
[TBL] [Abstract][Full Text] [Related]
11. Bone mineral density during reduction, maintenance and regain of body weight in premenopausal, obese women.
Fogelholm GM; Sievänen HT; Kukkonen-Harjula TK; Pasanen ME
Osteoporos Int; 2001; 12(3):199-206. PubMed ID: 11315238
[TBL] [Abstract][Full Text] [Related]
12. Effects of obesity and diabetes on rate of bone density loss.
Leslie WD; Morin SN; Majumdar SR; Lix LM
Osteoporos Int; 2018 Jan; 29(1):61-67. PubMed ID: 28917003
[TBL] [Abstract][Full Text] [Related]
13. High serum 25-hydroxyvitamin D levels do not retard postmenopausal bone loss in Japanese women: the Yokogoshi study.
Kitamura K; Nakamura K; Saito T; Kobayashi R; Oshiki R; Nishiwaki T; Iwasaki M; Yoshihara A
Arch Osteoporos; 2013; 8():153. PubMed ID: 24105337
[TBL] [Abstract][Full Text] [Related]
14. The levels of bone turnover markers in Chinese postmenopausal women: Peking Vertebral Fracture study.
Zhao J; Xia W; Nie M; Zheng X; Wang Q; Wang X; Wang W; Ning Z; Huang W; Jiang Y; Li M; Wang O; Xing X; Sun Y; Luo L; He S; Yu W; Lin Q; Pei Y; Zhang F; Han Y; Tong Y; Che Y; Shen R; Hu Y; Zhou X; Xu L
Menopause; 2011 Nov; 18(11):1237-43. PubMed ID: 21747303
[TBL] [Abstract][Full Text] [Related]
15. [Effect of raloxifene hydrochloride on bone mineral density, bone metabolism and serum lipids in Chinese postmenopausal women with osteoporosis].
Liu JL; Zhu HM; Huang QR; Zhang ZL; Li HL; Qin YJ; Zhang Y; Wei DL; Lu JH; Liu H; Chen XP; Liu YJ; Ekangaki A; Zheng YM; Diez-Perez A; Harpe K
Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):269-73. PubMed ID: 15059505
[TBL] [Abstract][Full Text] [Related]
16. Estimation of serum osteocalcin and telopeptide-C in postmenopausal osteoporotic females.
Lateef M; Baig M; Azhar A
Osteoporos Int; 2010 May; 21(5):751-5. PubMed ID: 19597912
[TBL] [Abstract][Full Text] [Related]
17. Effects of transdermal estradiol delivered by a matrix patch on bone density in hysterectomized, postmenopausal women: a 2-year placebo-controlled trial.
Arrenbrecht S; Boermans AJ
Osteoporos Int; 2002; 13(2):176-83. PubMed ID: 11908492
[TBL] [Abstract][Full Text] [Related]
18. Romosozumab increases bone mineral density in postmenopausal Japanese women with osteoporosis: A phase 2 study.
Ishibashi H; Crittenden DB; Miyauchi A; Libanati C; Maddox J; Fan M; Chen L; Grauer A
Bone; 2017 Oct; 103():209-215. PubMed ID: 28687496
[TBL] [Abstract][Full Text] [Related]
19. Natural history and risk factors for bone loss in postmenopausal Caucasian women: a 15-year follow-up population-based study.
Zhai G; Hart DJ; Valdes AM; Kato BS; Richards JB; Hakim A; Spector TD
Osteoporos Int; 2008 Aug; 19(8):1211-7. PubMed ID: 18305885
[TBL] [Abstract][Full Text] [Related]
20. The first multicenter and randomized clinical trial of herbal Fufang for treatment of postmenopausal osteoporosis.
Zhu HM; Qin L; Garnero P; Genant HK; Zhang G; Dai K; Yao X; Gu G; Hao Y; Li Z; Zhao Y; Li W; Yang J; Zhao X; Shi D; Fuerst T; Lu Y; Li H; Zhang X; Li C; Zhao J; Wu Q; Zhao SJ
Osteoporos Int; 2012 Apr; 23(4):1317-27. PubMed ID: 21505910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
